Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerhard Ehninger

Showing results (21-30 of 403) with videos related to

Pageof 41
Sort By:
Leukemia Research|February 4, 2012
The clinical, quality of life, and economic consequences of chronic anemia and transfusion support in patients with myelodysplastic syndromesUwe Platzbecker, Lorenz C Hofbauer, Gerhard Ehninger, et al.
Anticancer Research|January 31, 2012
Polymorphisms of the epidermal growth factor receptor (EGFR) and survival in patients with advanced cancer of the head and neck (HNSCC)Jan Stoehlmacher-Williams, Luise Obermann, Gerhard Ehninger, et al.
Plos One|February 6, 2014
Toward an optimal global stem cell donor recruitment strategyAlexander H Schmidt, Jürgen Sauter, Julia Pingel, et al.
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie|November 2, 2013
Efficacy and side effects of granulocyte collection in healthy donorsFranziska Brockmann, Michael Kramer, Martin Bornhäuser, et al.
Cancer Immunology, Immunotherapy : CII|May 12, 2005
T cell-mediated graft-versus-leukemia reactions after allogeneic stem cell transplantationJohannes Schetelig, Alexander Kiani, Marc Schmitz, et al.
British Journal of Haematology|November 28, 2008
Regulation of Down Syndrome Critical Region 1 expression by Nuclear Factor of Activated T cells in megakaryocytesSatu Kyttälä, Ivonne Habermann, Takashi Minami, et al.
Current Opinion in Hematology|January 11, 2022
Chimeric antigen receptor T-cell therapy in acute myeloid leukemiaJan Koedam, Martin Wermke, Armin Ehninger, et al.
Leukemia Research|November 22, 2002
Up-front randomization and common standard arm: a proposal for comparing AML treatment strategies between different studiesThomas Büchner, Hartmut Döhner, Gerhard Ehninger, et al.
Plos One|February 17, 2017
Lipidomic approach for stratification of acute myeloid leukemia patientsAdam Stefanko, Christian Thiede, Gerhard Ehninger, et al.
British Journal of Haematology|August 30, 2002
CD34+-enriched peripheral blood progenitor cells from unrelated donors for allografting of adult patients: high risk of graft failure, infection and relapse despite donor lymphocyte add-backMartin Bornhäuser, Uwe Platzbecker, Catrin Theuser, et al.
Pageof 41

Showing results (21-30 of 403) with videos related to

Sort By:
Pageof 41
Leukemia Research|February 4, 2012
The clinical, quality of life, and economic consequences of chronic anemia and transfusion support in patients with myelodysplastic syndromesUwe Platzbecker, Lorenz C Hofbauer, Gerhard Ehninger, et al.
Anticancer Research|January 31, 2012
Polymorphisms of the epidermal growth factor receptor (EGFR) and survival in patients with advanced cancer of the head and neck (HNSCC)Jan Stoehlmacher-Williams, Luise Obermann, Gerhard Ehninger, et al.
Plos One|February 6, 2014
Toward an optimal global stem cell donor recruitment strategyAlexander H Schmidt, Jürgen Sauter, Julia Pingel, et al.
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie|November 2, 2013
Efficacy and side effects of granulocyte collection in healthy donorsFranziska Brockmann, Michael Kramer, Martin Bornhäuser, et al.
Cancer Immunology, Immunotherapy : CII|May 12, 2005
T cell-mediated graft-versus-leukemia reactions after allogeneic stem cell transplantationJohannes Schetelig, Alexander Kiani, Marc Schmitz, et al.
British Journal of Haematology|November 28, 2008
Regulation of Down Syndrome Critical Region 1 expression by Nuclear Factor of Activated T cells in megakaryocytesSatu Kyttälä, Ivonne Habermann, Takashi Minami, et al.
Current Opinion in Hematology|January 11, 2022
Chimeric antigen receptor T-cell therapy in acute myeloid leukemiaJan Koedam, Martin Wermke, Armin Ehninger, et al.
Leukemia Research|November 22, 2002
Up-front randomization and common standard arm: a proposal for comparing AML treatment strategies between different studiesThomas Büchner, Hartmut Döhner, Gerhard Ehninger, et al.
Plos One|February 17, 2017
Lipidomic approach for stratification of acute myeloid leukemia patientsAdam Stefanko, Christian Thiede, Gerhard Ehninger, et al.
British Journal of Haematology|August 30, 2002
CD34+-enriched peripheral blood progenitor cells from unrelated donors for allografting of adult patients: high risk of graft failure, infection and relapse despite donor lymphocyte add-backMartin Bornhäuser, Uwe Platzbecker, Catrin Theuser, et al.
Pageof 41